A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria (Q34200855)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria |
scientific article |
Statements
1 reference
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria (English)
1 reference
Marcus Maurer
1 reference
Sarbjit Saini
1 reference
Karin E Rosen
1 reference
Hsin-Ju Hsieh
1 reference
Dennis A Wong
1 reference
Edward Conner
1 reference
Allen Kaplan
1 reference
Sheldon Spector
1 reference
1 reference
Identifiers
1 reference